Abuse and dependence potential for the non‐benzodiazepine hypnotics zolpidem and zopiclone: a review of case reports and epidemiological data

G Hajak, WE Müller, HU Wittchen, D Pittrow… - Addiction, 2003 - Wiley Online Library
Aims The non‐benzodiazepine hypnotics zolpidem and zopiclone, which are indicated for
short‐term treatment of insomnia, were considered originally by physicians as almost devoid …

Role of endothelin and endothelin receptor antagonists in renal disease

W Neuhofer, D Pittrow - European journal of clinical …, 2006 - Wiley Online Library
Endothelin (ET)‐1 is a potent vasoconstrictor peptide with pro‐inflammatory, mitogenic, and
pro‐fibrotic properties that is closely involved in both normal renal physiology and pathology…

Low-grade albuminuria and cardiovascular risk: what is the evidence?

…, U Tebbe, WD Paar, P Bramlage, D Pittrow… - Clinical Research in …, 2007 - Springer
Microalbuminuria (MA), conventionally defined as a urinary albumin excretion (UAE) of 30–300
mg/day, is recognised as a marker of endothelial dysfunction. Furthermore, it represents …

High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross-sectional study

…, JR Allenberg, H Darius, R Haberl, S Lange, D Pittrow… - Atherosclerosis, 2004 - Elsevier
We aimed to obtain reliable data on the epidemiology, co-morbidities and risk factor profile
of peripheral arterial disease (PAD) in general medical practise. In the cross-sectional part of …

Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model

…, HA Ghofrani, D Huscher, D Pittrow… - European …, 2017 - Eur Respiratory Soc
… and high risk of death; 2) this risk stratification strategy was valid for baseline and follow-up
assessments; 3) risk prediction proved accurate for subgroups of patients with I/D/H-PAH and …

Elderly patients diagnosed with idiopathic pulmonary arterial hypertension: results from the COMPERA registry

…, H Kaemmerer, JSR Gibbs, D Pittrow - International journal of …, 2013 - Elsevier
Background Originally reported to occur predominantly in younger women, idiopathic pulmonary
arterial hypertension (IPAH) is increasingly diagnosed in elderly patients. We aimed to …

Mortality and vascular morbidity in older adults with asymptomatic versus symptomatic peripheral artery disease

C Diehm, JR Allenberg, D Pittrow, M Mahn, G Tepohl… - Circulation, 2009 - Am Heart Assoc
Background— Our aim was to assess the mortality and vascular morbidity risk of elderly
individuals with asymptomatic versus symptomatic peripheral artery disease (PAD) in the …

The predictive value of different measures of obesity for incident cardiovascular events and mortality

…, M Dorr, S Felix, H Lehnert, D Pittrow… - The Journal of …, 2010 - academic.oup.com
Context: To date, it is unclear which measure of obesity is the most appropriate for risk
stratification. Objective: The aim of the study was to compare the associations of various measures …

Anticoagulation and survival in pulmonary arterial hypertension: results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary …

…, J Pepke-Zaba, U Schulz, M Gorenflo, D Pittrow… - Circulation, 2014 - Am Heart Assoc
… Dr Pittrow has received speaker fees or honoraria for consultations from Actelion, Bayer,
Boehringer Encysive, Ingelheim, Encysive, Novartis, and Pfizer. Dr Hoeper has received …

[HTML][HTML] COMPERA 2.0: a refined four-stratum risk assessment model for pulmonary arterial hypertension

…, KM Olsson, D Huscher, D Pittrow… - European …, 2022 - Eur Respiratory Soc
… -up with the four-stratum model a) from intermediate-low risk to other risk categories, b) from
intermediate-high risk to other risk categories, c) from high risk to other risk categories and d